1. Stocks
  2. Protagonist Therapeutics Inc
  3. Swot
swot-logo

Protagonist Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Protagonist Therapeutics Inc has 21 Strengths, 7 Weaknesses, 0 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Turnaround Potential (DVM)

Consistent Highest Return Stocks over Five Years

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over the Quarter (3 Months)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Stock gained more than 20% in one month

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Top Gainers

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)

Declining Net Cash Flow : Companies not able to generate net cash

Recent Results: Declining Operating Profit Margin and Net Profits (YoY)

Profit to Loss Companies

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks